<DOC>
	<DOCNO>NCT01289353</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness combination chemotherapy radiotherapy breast cancer patient breast surgery .</brief_summary>
	<brief_title>Concurrent Adjuvant Carboplatin Accelerated Radiotherapy Triple Negative Breast Cancer</brief_title>
	<detailed_description>Preliminary experience neo-adjuvant setting Locally Advanced Breast Cancer ( LABC ) recently demonstrate hormone receptor negative patient approximately 50 % chance achieve pathological response concurrent chemo-radiation . In multi-institutional collaboration 105 patient found triple negative ( TN ) tumor carrier achieve pathological response 54 % case response reflect 5-year disease free survival overall survival . Our group speculate effect risk distant recurrence could depend recovery antitumor immunity among patient achieve pathological response , tumor cell death induced concurrent chemo-radiation . The investigator propose novel study translate finding adjuvant set TN tumor . TN breast cancer aggressive form disease often coincide basal-like tumor . BRCA mutated-cancer frequently TN . The current protocol converges experience NYU develop accelerate prone breast radiotherapy encourage find use concurrent chemoradiation LABC . The investigator study feasibility combine weekly carboplatin concurrent 3-weeks prone breast radiotherapy adjuvant set 35 woman TN tumor , segmental mastectomy nodal assessment . Primary endpoint study acute toxicity combine regimen , target &lt; 25 % grade II-III dermatitis .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Age old 18 Pre postmenopausal woman Stage I II breast cancer , triple negative tumor Biopsyproven invasive breast cancer , excise negative margin least 1 mm Status post segmental mastectomy , sentinel node biopsy and/or axillary node dissection ( Tumors &lt; 5 mm size require nodal assessment ) mastectomy No previous chemotherapy Patient need able understand demonstrate willingness sign write informed consent document Previous radiation therapy ipsilateral breast Active connective tissue disorder , lupus scleroderma Pregnant lactating woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>triple negative</keyword>
	<keyword>breast cancer</keyword>
	<keyword>adjuvant therapy</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>chemo-radiotherapy</keyword>
	<keyword>accelerate radiotherapy</keyword>
</DOC>